Genetic alterations also play a critical role, with gain-of-function mutations or amplifications in PIK3CA—encoding the p110α subunit of PI3K—present in roughly 30% of HNSCC lesions [59]. Here, PIK3CA is linked to head and neck squamous cell carcinoma.